The following discussion and analysis summarizes the significant factors
affecting the consolidated operating results, financial condition, liquidity and
cash flows of our Company as of and for the periods presented below. The
following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our unaudited condensed
consolidated financial statements and related notes included in this Quarterly
Report on Form 10-Q and the audited financial statements and notes thereto, and
related disclosures, as of and for the year ended June 30, 2022, which are
included in the Form 10-K filed with the Securities and Exchange Commission (the
"SEC") on September 28, 2022. Unless the context requires otherwise, references
in this Quarterly Report on Form 10-Q to "we," "us," "our" or "the Company,"
refer to The Glimpse Group, Inc., a Nevada corporation and its subsidiaries.



Forward-Looking Statements



The information in this discussion contains forward-looking statements and
information within the meaning of Section 27A of the Securities Act of 1933, as
amended, or the Securities Act, and Section 21E of the Securities Exchange Act
of 1934, as amended, (the "Exchange Act"), which are subject to the "safe
harbor" created by those sections. These forward-looking statements include, but
are not limited to, statements concerning our strategy, future operations,
future financial position, future revenues, projected costs, prospects and plans
and objectives of management. The words "anticipates," "believes," "estimates,"
"expects," "intends," "may," "plans," "projects," "will," "would" and similar
expressions are intended to identify forward-looking statements, although not
all forward-looking statements contain these identifying words. We may not
actually achieve the plans, intentions, or expectations disclosed in our
forward-looking statements and you should not place undue reliance on our
forward-looking statements. Actual results or events could differ materially
from the plans, intentions and expectations disclosed in the forward-looking
statements that we make. These forward-looking statements involve risks and
uncertainties that could cause our actual results to differ materially from
those in the forward-looking statements, including, without limitation, the
risks set forth in Part II, Item 1A, "Risk Factors" in this Quarterly Report on
Form 10-Q and in our other filings with the SEC. The forward-looking statements
are applicable only as of the date on which they are made, and we do not assume
any obligation to update any forward-looking statements.



Overview



We are a Virtual ("VR") and Augmented ("AR") Reality platform company, comprised
of a diversified group of wholly-owned and operated VR and AR companies,
providing enterprise-focused software, services and solutions. We believe that
we offer significant exposure to the rapidly growing and potentially
transformative VR and AR markets, while mitigating downside risk via our
diversified model and ecosystem.



We were incorporated as The Glimpse Group, Inc. in the State of Nevada, on June
15, 2016 and are headquartered in New York, New York. We currently own and
operate numerous subsidiary companies ("Subsidiary Companies", "Subsidiaries")
operating under the following business names as represented in the
organizational chart below:


                               [[Image Removed]]
29







Significant Transactions


None since last filed 10Q.

Financial Highlights for the three and six months ended December 31, 2022 compared to the three and six months ended December 31, 2021





Results of Operations


The following table sets forth our results of operations for the three and six months ended December 31, 2022 and 2021:





Summary P&L



                           For the Three Months Ended                                  For the Six Months Ended
                                  December 31,                     Change                    December 31,                     Change
                            2022               2021             $          %            2022               2021            $          %
                                        (in millions)                                              (in millions)
Revenue                  $      2.95       $        1.69     $  1.26         75 %   $       6.90       $       2.71     $  4.19        155 %
Cost of Goods Sold              0.88                0.21        0.67        319 %           2.09               0.36        1.73        481 %
Gross Profit                    2.07                1.48        0.59         40 %           4.81               2.35        2.46        105 %
Total Operating
Expenses                        0.84                3.05       (2.21 )      -72 %           9.01               5.32        3.69         69 %
Income (Loss) from
Operations before
Other Income (Expense)          1.23               (1.57 )      2.80        178 %          (4.20 )            (2.97 )     (1.23 )       41 %
Other Income
(Expense), net                  0.08                   -        0.08        N/A             0.13              (0.26 )      0.39        150 %
Net Income (Loss)        $      1.31       $       (1.57 )   $  2.88        183 %   $      (4.07 )     $      (3.23 )   $ (0.84 )       26 %




30







Revenue



                             For the Three Months Ended                                   For the Six Months Ended
                                    December 31,                       Change                   December 31,                    Change
                             2022                  2021             $          %           2022              2021            $          %
                                          (in millions)                                               (in millions)
Software Services        $        2.89         $        1.61     $  1.28         80 %   $      6.75       $      2.42     $  4.33        179 %
Software
License/Software as a
Service                           0.06                  0.08       (0.02 )      -25 %          0.15              0.29       (0.14 )      -48 %
Total Revenue            $        2.95         $        1.69     $  1.26         75 %   $      6.90       $      2.71     $  4.19        155 %




Total revenue for the three months ended December 31, 2022 was approximately
$2.95 million compared to approximately $1.69 million for the three months ended
December 31, 2021, an increase of 75%. Total revenue for the six months ended
December 31, 2022 was approximately $6.90 million compared to approximately
$2.71 million for the six months ended December 31, 2021, an increase of 155%.
The increase for both periods reflect the addition of several subsidiary
companies after December 31, 2021 and new customers.



We break out our revenues into two main categories - Software Services and Software License.

? Software Services revenues are primarily comprised of VR/AR projects, services

related to our software licenses and consulting retainers.

? Software License revenues are comprised of the sale of our internally

developed VR/AR software as licenses or as software-as-a-service ("SaaS").


For the three months ended December 31, 2022, Software Services revenue was
approximately $2.89 million compared to approximately $1.61 million for the
three months ended December 31, 2021, an increase of approximately 80%. For the
six months ended December 31, 2022, Software Services revenue was approximately
$6.75 million compared to approximately $2.42 million for the six months ended
December 31, 2021, an increase of approximately 179%. The increase for both
periods reflect the addition of several subsidiary companies after December

31,
2021 and new customers.



For the three months ended December 31, 2022, Software License revenue was
approximately $0.06 million compared to approximately $0.08 million for the
three months ended December 31, 2021, consistent period over period. For the six
months ended December 31, 2022, Software License revenue was approximately $0.15
million compared to approximately $0.29 million for the six months ended
December 31, 2021, reflecting a long term license agreement in the 2021 period.
As the VR and AR industries continue to mature, we expect our Software License
revenue to continue to grow on an absolute basis and as an overall percentage of
total revenue.



For the three months ended December 31, 2022, non-project revenue (i.e., VR/AR
Software and Services revenue only), was approximately $0.93 million compared to
approximately $0.85 million for the three months ended December 31, 2021, an
increase of approximately 9%, reflecting organic growth and the addition of new
customers. For the three months ended December 31, 2022, non-project revenue
accounted for approximately 32% of total revenues compared to approximately 50%
for the three months ended December 31, 2021. For the six months ended December
31, 2022, non-project revenue (i.e., VR/AR Software and Services revenue only),
was approximately $2.21 million compared to approximately $1.70 million for the
six months ended December 31, 2021, an increase of approximately 30%, reflecting
organic growth and the addition of new customers. For the six months ended
December 31, 2022, non-project revenue accounted for approximately 32% of total
revenues compared to approximately 63% for the six months ended December 31,
2021. The decrease in both periods reflects the additions of Brightline
Interactive ("BLI") and Sector 5 Digital ("S5D"), which primarily generate
project revenue, representing an increased portion of total revenue.



Customer Concentration



Two customers accounted for approximately 55% (29% and 26%, respectively) of the
Company's total gross revenues during the three months ended December 31, 2022.
One of the same customers and a different customer accounted for approximately
75% (45% and 30%, respectively) of the Company's total gross revenues during the
three months ended December 31, 2021. Two customers accounted for approximately
56% (29% and 27%, respectively) of the Company's total gross revenues during the
six months ended December 31, 2022. One of the same customers and a different
customer accounted for approximately 67% (49% and 18%, respectively) of the
Company's total gross revenues during the six months ended December 31, 2021.



31







We operate in an early stage industry, and customers are exploring various
options for AR and VR solutions and acting as early adopters. As such, there can
be a high degree of variance on our source of revenues while customers are
on-boarded and our software products and solutions are integrated, measured and
digested. A customer that may account for a higher percentage of revenue in one
period may not account for any revenue in subsequent periods. In some cases,
those customers could re-engage after they have evaluated our solutions and may
or may not be a source of future revenue. Recently, a significant percentage of
our revenues have come from two strategic customers. A reduction of revenue from
these strategic customers - which we do not currently anticipate - would have a
detrimental impact on the Company's revenues. The addition of BLI and S5D has
reduced the reliance on a single customer. In general, a customer that makes up
a significant portion of revenues in one period, often does not make up a
significant portion in other periods. Given this dynamic we expect this
variability in Customer Concentration to continue until such point in time when
our revenue has reached larger scale, and with a larger portion of our revenues
coming from Software Licenses/SaaS.



Gross Profit



                             For the Three Months Ended                                  For the Six Months Ended
                                    December 31,                      Change                   December 31,                   Change
                             2022                  2021            $          %           2022              2021           $          %
                                         (in millions)                                              (in millions)
Revenue                  $        2.95         $        1.69     $ 1.26

75 % $ 6.90 $ 2.71 $ 4.19 155 % Cost of Goods Sold

                0.88                  0.21       0.67        319 %   $      2.09              0.36       1.73        481 %
Gross Profit                      2.07                  1.48       0.59         40 %          4.81              2.35       2.46        105 %
Gross Profit Margin                 70 %                  88 %             

                    70 %              87 %




Gross profit was approximately 70% for the three months ended December 31, 2022
compared to approximately 88% for the three months ended December 31, 2021.
Gross profit was approximately 70% for the six months ended December 31, 2022
compared to approximately 87% for the six months ended December 31, 2021. The
decrease for both periods was driven by the addition of BLI and S5D lower margin
project revenue.



For the three months ended December 31, 2022 and 2021, internal staffing was
approximately $0.50 million (57% of total cost of goods sold) and approximately
$0.18 million (86% of total cost of goods sold), respectively. For the six
months ended December 31, 2022 and 2021, internal staffing was approximately
$1.25 million (60% of total cost of goods sold) and approximately $0.32 million
(89% of total cost of goods sold), respectively. The decrease for both periods
in internal staffing as a percentage of total cost of goods sold was due to the
addition of BLI and S5D, which have a higher utilization of external sources.



Operating Expenses



                           For the Three Months Ended                                  For the Six Months Ended
                                  December 31,                     Change                    December 31,                     Change
                             2022               2021            $          %            2022               2021            $          %
                                        (in millions)                                              (in millions)

Research and
development expenses     $        2.53       $      1.19     $  1.34        113 %   $        4.53       $      2.18     $  2.35        108 %
General and
administrative
expenses                          1.26              1.13        0.13         12 %            2.63              1.89        0.74         39 %
Sales and marketing
expenses                          1.93              0.66        1.27        192 %            3.68              1.17        2.51        215 %
Amortization of
acquisition intangible
assets                            0.54              0.07        0.47        671 %            0.99              0.08        0.91       1138 %
Change in fair value
of acquisition
contingent
consideration                    (5.42 )               -       (5.42 )      N/A             (2.82 )               -       (2.82 )      N/A
Total Operating
Expenses                 $        0.84       $      3.05     $ (2.21 )      -72 %   $        9.01       $      5.32     $  3.69         69 %




Operating expenses for the three months ended December 31, 2022 were
approximately $0.84 million compared to $3.05 million for the three months ended
December 31, 2021, a decrease of approximately 72%. The decrease is driven by a
gain in the change in fair value of contingent consideration for the S5D and BLI
acquisitions; offset by expenses related to the addition of several new
subsidiaries (which includes headcount, amortization of intangibles and
professional fees related to the acquisitions) and employee headcount additions
to support growth.



32







Operating expenses for the six months ended December 31, 2022 were approximately
$9.01 million compared to $5.32 million for the six months ended December 31,
2021, an increase of approximately 69%. The increase is driven by expenses
related to the addition of several new subsidiaries (which includes headcount,
amortization of intangibles and professional fees related to the acquisitions)
and employee headcount additions to support growth; offset by a gain in the
change in fair value of contingent consideration for the S5D and BLI
acquisitions.



Research and Development



Research and development expenses for the three months ended December 31, 2022
were approximately $2.53 million compared to $1.19 million for the three months
ended December 31, 2021, an increase of approximately 113%. Research and
development expenses for the six months ended December 31, 2022 were
approximately $4.53 million compared to $2.18 million for the six months ended
December 31, 2021, an increase of approximately 108%. For both periods, this
reflects the addition of several new subsidiaries and headcount additions to
support growth. Going forward, we expect research and development costs to
continue to increase as we continue to develop and commercialize our software
products.



For the three months ended December 31, 2022, non-cash stock option expenses
relating to research and development included approximately $0.38 million of
employee compensation expenses, comprising approximately 15% of total research
and development expenses. For the three months ended December 31, 2021, non-cash
stock option expenses relating to research and development included
approximately $0.26 million of employee compensation expenses, comprising
approximately 22% of total research and development expenses. For the six months
ended December 31, 2022, non-cash stock option expenses relating to research and
development included approximately $0.77 million of employee compensation
expenses, comprising approximately 17% of total research and development
expenses. For the six months ended December 31, 2021, non-cash stock option
expenses relating to research and development included approximately $0.61
million of employee compensation expenses, comprising approximately 28% of total
research and development expenses. Over time, we expect non-cash stock options
research and development expenses, as a percentage of the total related
expenses, to continue to decrease as we utilize a larger portion of cash for
compensation thereby minimizing dilution.



General and Administrative



General and administrative expenses for the three months ended December 31, 2022
were approximately $1.26 million compared to $1.13 million for the three months
ended December 31, 2021, an increase of approximately 12%. General and
administrative expenses for the six months ended December 31, 2022 were
approximately $2.63 million compared to $1.89 million for the six months ended
December 31, 2021, an increase of approximately 39%. The increase for both
periods primarily reflects expenses related to the addition of several new
subsidiaries (which includes headcount, professional fees related to the
acquisitions and facility costs) and additional independent board members.



For the three months ended December 31, 2022, non-cash stock option expenses
relating to general and administrative expenses included approximately $0.18
million of employee and board of directors expenses, comprising approximately
14% of total general and administrative expenses. For the three months ended
December 31, 2021, non-cash stock option and common stock expenses relating to
general and administrative expenses included approximately $0.24 million of
employee, board of directors and vendor expenses, comprising approximately 21%
of total general and administrative expenses. For the six months ended December
31, 2022, non-cash stock option expenses relating to general and administrative
expenses included approximately $0.38 million of employee and board of directors
expenses, comprising approximately 14% of total general and administrative
expenses. For the six months ended December 31, 2021, non-cash stock option and
common stock expenses relating to general and administrative expenses included
approximately $0.46 million of employee, board of directors and vendor expenses,
comprising approximately 24% of total general and administrative expenses. Over
time, we expect non-cash stock options and common stock general and
administrative expenses, as a percentage of the total related expenses, to
continue to decrease as we utilize a larger portion of cash for compensation
thereby minimizing dilution.



33







Sales and Marketing



Sales and marketing expenses for the three months ended December 31, 2022 were
approximately $1.93 million compared to $0.66 million for the three months ended
December 31, 2021, an increase of approximately 192%. Sales and marketing
expenses for the six months ended December 31, 2022 were approximately $3.68
million compared to $1.17 million for the six months ended December 31, 2021, an
increase of approximately 215%. The increase for both periods reflect expenses
related to the addition of several new subsidiaries and expansions to headcount
and outside marketing firms to drive revenue growth. As our subsidiary companies
continue to establish initial market traction and grow their revenue base, we
expect to increase our business development and sales expenses.



For the three months ended December 31, 2022, non-cash stock option and common
stock expenses relating to sales and marketing expenses included approximately
$0.14 million of employee compensation expenses, comprising approximately 7% of
total sales and marketing expenses. For the three months ended December 31,
2021, non-cash stock option and common stock expenses relating to sales and
marketing expenses included approximately $0.20 million of employee, vendor and
fee compensation expenses, comprising approximately 30% of total sales and
marketing expenses. For the six months ended December 31, 2022, non-cash stock
option and common stock expenses relating to sales and marketing expenses
included approximately $0.52 million of employee compensation expenses,
comprising approximately 14% of total sales and marketing expenses. For the six
months ended December 31, 2021, non-cash stock option and common stock expenses
relating to sales and marketing expenses included approximately $0.33 million of
employee, vendor and fee compensation expenses, comprising approximately 28% of
total sales and marketing expenses. Over time, we expect non-cash stock options
and common stock sales and marketing expenses, as a percentage of the total
related expenses, to continue to decrease as we utilize a larger portion of cash
for compensation thereby minimizing dilution.



Amortization of Acquisition Intangible Assets


Amortization of acquisition intangible assets expense for the three months ended
December 31, 2022 was approximately $0.54 million compared to $0.07 million for
the three months ended December 31, 2021. Amortization of acquisition intangible
assets expense for the six months ended December 31, 2022 were approximately
$0.99 million compared to $0.08 million for the six months ended December 31,
2021. For both periods, this primarily reflects the addition of several new
subsidiaries.



Change in Fair Value of Acquisition Contingent Consideration





Change in fair value of acquisition contingent consideration expense for the
three and six months ended December 31, 2022 was a gain of approximately $5.42
and $2.82 million, respectively. For both periods, this represents a decrease in
the fair value of the contingent consideration liability related to the S5D and
BLI acquisitions. The change in both periods is driven by a decrease in the
common stock price of Glimpse between measurement dates and revisions to revenue
projections.



Other Income (Expense), net



                          For the Three Months Ended                                For the Six Months Ended
                                 December 31,                   Change                    December 31,                    Change
                           2022               2021           $          %           2022               2021            $          %
                                      (in millions)                                            (in millions)

Interest income          $   0.08         $          -     $ 0.08        N/A     $      0.13       $        0.02     $ 0.11        550 %
Loss on conversion of
convertible notes               -                    -          -        N/A               -               (0.28 )     0.28        N/A
Other Income
(Expense), net           $   0.08         $          -     $ 0.08        N/A     $      0.13       $       (0.26 )   $ 0.39       -150 %




Other income for the three months ended December 31, 2022 was income of $0.08
million compared to zero for the three months ended December 31, 2021. Other
income and expense, net for the six months ended December 31, 2022 was income of
$0.13 million compared to an expense of $0.26 million for the six months ended
December 31, 2021. The change is driven by a loss incurred on conversion of
convertible debt to common stock that occurred at the IPO in the 2021 period.
Income for all periods reflects interest income on cash and cash equivalent

balances.



34







Net Income (Loss)



Net income for the three months ended December 31, 2022 was $1.31 million, as
compared to a net loss of $1.57 million for the comparable 2021 period, an
absolute change of $2.88 million. This change is driven by the non-cash gain on
the change in fair value of acquisition contingent consideration, partially
offset by the increase in operating expenses from the acquisition of several
subsidiaries. We sustained a net loss of $4.07 million for the six months ended
December 31, 2022 as compared to a net loss of $3.23 million for the comparable
2021 period, a loss increase of $0.84 million. This change is driven by the
increase in operating expenses from the acquisition of several subsidiaries,
partially offset by the non-cash gain on change in fair value of acquisition
contingent consideration.



Non-GAAP Financial Measures



The following discussion and analysis includes both financial measures in
accordance with Generally Accepted Accounting Principles, or GAAP, as well as
non-GAAP financial measures. Generally, a non-GAAP financial measure is a
numerical measure of a company's performance, financial position or cash flows
that either excludes or includes amounts that are not normally included or
excluded in the most directly comparable measure calculated and presented in
accordance with GAAP. Non-GAAP financial measures should be viewed as
supplemental to, and should not be considered as alternatives to, net income
(loss), operating income (loss), and cash flow from operating activities,
liquidity or any other financial measures. They may not be indicative of the
historical operating results of the Company nor are they intended to be
predictive of potential future results. Investors should not consider non-GAAP
financial measures in isolation or as substitutes for performance measures
calculated in accordance with GAAP. Our management uses and relies on EBITDA and
Adjusted EBITDA, which are non-GAAP financial measures. We believe that both
management and shareholders benefit from referring to the following non-GAAP
financial measures in planning, forecasting and analyzing future periods.



Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the described excluded items.





The Company defines Adjusted EBITDA as earnings (or loss) from continuing
operations before the items in the table below. Adjusted EBITDA is an important
measure of our operating performance because it allows management, investors and
analysts to evaluate and assess our core operating results from period-to-period
after removing the impact of items of a non-operational nature that affect
comparability.



We have included a reconciliation of our financial measures calculated in
accordance with GAAP to the most comparable non-GAAP financial measures. We
believe that providing the non-GAAP financial measures, together with the
reconciliation to GAAP, helps investors make comparisons between the Company and
other companies. In making any comparisons to other companies, investors need to
be aware that companies use different non-GAAP measures to evaluate their
financial performance. Investors should pay close attention to the specific
definition being used and to the reconciliation between such measures and the
corresponding GAAP measures provided by each company under applicable SEC rules.



35






The following table presents a reconciliation of net income (loss) to Adjusted EBITDA for the three and six months ended December 31, 2022 and 2021:





                                      For the Three Months Ended            For the Six Months Ended
                                             December 31,                         December 31,
                                       2022                2021              2022               2021
                                             (in millions)                        (in millions)
Net income (loss)                  $        1.31       $       (1.57 )   $      (4.07 )     $      (3.23 )
Depreciation and amortization               0.58                0.08             1.06               0.10
EBITDA (loss)                               1.89               (1.49 )          (3.01 )            (3.13 )
Stock based compensation
expenses                                    0.74                0.59             1.72               1.31
Stock based acquisition expense             0.20                   -             0.20                  -
Stock based financing related
expenses                                       -                   -                -               0.28
Acquisition related expenses                0.01                0.09             0.28               0.10
Change in fair value of
acquisition contingent
consideration                              (5.42 )                 -            (2.82 )                -
Adjusted EBITDA (loss)             $       (2.58 )     $       (0.81 )   $ 

    (3.63 )     $      (1.44 )




Adjusted EBITDA loss of $2.58 million for the three months ended December 31,
2022 increased by $1.77 million compared to a $0.81 million loss for the three
months ended December 31, 2021. Adjusted EBITDA loss of $3.63 million for the
six months ended December 31, 2022 increased by $2.19 million compared to a
$1.44 million loss for the six months ended December 31, 2021. The increases in
EBITDA loss were driven by an increase in operating expense outlays in all areas
of the Company to propel future growth, including the acquisition of several new
subsidiaries. This is offset primarily by non-cash expenses, both stock based
and fair value driven.


Liquidity and Capital Resources





                                      For the Six Months Ended
                                            December 31,                        Change
                                       2022               2021             $              %
                                                   (in millions)
Net cash used in operating
activities                         $      (6.49 )     $      (2.36 )   $    (4.13 )         -175 %
Net cash used in investing
activities                                (2.60 )            (0.59 )        (2.01 )         -341 %
Net cash provided by financing
activities                                 0.04              26.01         (25.97 )         -100 %
Net increase (decrease) in cash
and cash equivalents                      (9.05 )            23.06         (32.11 )         -139 %
Cash, cash equivalents and
restricted cash, beginning of
period                                    18.25               1.77          16.48            931 %

Cash, cash equivalents and restricted cash, end of period $ 9.20 $ 24.83 $ (15.63 ) -63 %






Operating Activities



Net cash used in operating activities was $6.49 million for the six months ended
December 31, 2022, compared to $2.36 million during the prior period, an
increase of approximately $4.13 million. This is primarily driven by an increase
in net loss and a decrease in accounts payable and deferred revenue primarily
related to the BLI acquisition, offset by increased non-cash expenses (primarily
acquisition contingent consideration fair value adjustment, stock based expenses
and intangible asset amortization).



Investing Activities



Net cash used in investing activities for the six months ended December 31, 2022
was approximately $2.6 million compared to $0.59 million during the prior
period, an increase of approximately $2.01 million. This primarily represents
the cash portion of the BLI acquisition.



Financing Activities



Cash flow provided from financing activities during the six months ended
December 31, 2022 was negligible, compared to $26.01 million for the prior 2021
period. Cash flow for the 2021 period primarily reflects the net proceeds from
our IPO and Securities Purchase Agreement.



36







Capital Resources



As of December 31, 2022, the Company had cash, cash equivalents and restricted
cash balances of $9.20 million, plus $0.2 million of liquid corporate bond
investments. The December 31, 2022 balances include $2.0 million cash escrow for
potential future contingent consideration of the S5D acquisition, payable upon
achievement of S5D and the Company's performance targets (refundable to Glimpse
if targets not achieved).


As of December 31, 2022, the Company had no outstanding debt obligations.

As of December 31, 2022, the Company had no issued and outstanding preferred stock.

The Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date of this filing.

Recently Adopted Accounting Pronouncements

Please see Note 3 of the attached December 31, 2022 consolidated financial statements that describe the impact, if any, from the adoption of Recent Accounting Pronouncements.

© Edgar Online, source Glimpses